Literature DB >> 14634552

Vaginal delivery parameters and urinary incontinence: the Norwegian EPINCONT study.

Guri Rortveit1, Anne Kjersti Daltveit, Yngvild S Hannestad, Steinar Hunskaar.   

Abstract

OBJECTIVE: The study was undertaken to investigate the effect of nine delivery parameters on urinary incontinence in later life. STUDY
DESIGN: Incontinence data from the EPINCONT study were linked to the Medical Birth Registry of Norway. Effects of birth weight, gestational age, head circumference, breech delivery, injuries in the delivery channel, functional delivery disorders, forceps delivery, vacuum delivery, and epidural anesthesia were investigated. The study covered women younger than 65 years, who had had vaginal deliveries only (n=11,397).
RESULTS: Statistically significant associations were observed between any incontinence and birth weight 4000 g or greater (odds ratio [OR] 1.1, 95% CI 1.0-1.2); moderate or severe incontinence and functional delivery disorders (OR 1.3, 95% CI 1.1-1.6); stress incontinence and high birth weight (OR 1.2, 95% CI 1.1-1.3) and epidural anesthesia (OR 1.2, 95% CI 1.0-1.5); and urge incontinence and head circumference 38 cm or larger (OR 1.8, 95% CI 1.0-3.3).
CONCLUSION: The effects were too weak to explain a substantial part of the association between vaginal delivery and urinary incontinence, and statistically significant results may have incurred by chance.

Entities:  

Mesh:

Year:  2003        PMID: 14634552     DOI: 10.1067/s0002-9378(03)00588-x

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  28 in total

1.  The effect of vaginal and cesarean delivery on lower urinary tract symptoms: what makes the difference?

Authors:  Henriette Jorien van Brummen; Hein W Bruinse; Geerte van de Pol; A Peter M Heintz; C Huub van der Vaart
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-04-21

Review 2.  Pharmacological management of women with mixed urinary incontinence.

Authors:  Hashim Hashim; Paul Abrams
Journal:  Drugs       Date:  2006       Impact factor: 9.546

3.  Increased duration of simulated childbirth injuries results in increased time to recovery.

Authors:  H Q Pan; J M Kerns; D L Lin; S Liu; N Esparza; M S Damaser
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2007-01-04       Impact factor: 3.619

4.  The effect of mode of delivery, parity, and birth weight on risk of urinary incontinence.

Authors:  Thomas J Connolly; Heather J Litman; Sharon L Tennstedt; Carol L Link; John B McKinlay
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-01-12

5.  Urinary incontinence symptoms during and after pregnancy in continent and incontinent primiparas.

Authors:  Angela D Thomason; Janis M Miller; John Ol Delancey
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-04-20

6.  The role of prepregnancy pelvic floor dysfunction in postnatal pelvic morbidity in primiparous women.

Authors:  C M Durnea; A S Khashan; L C Kenny; S S Tabirca; B A O'Reilly
Journal:  Int Urogynecol J       Date:  2014-04-23       Impact factor: 2.894

Review 7.  Preventing urinary incontinence during pregnancy and postpartum: a review.

Authors:  Stian Langeland Wesnes; Gunnar Lose
Journal:  Int Urogynecol J       Date:  2013-02-23       Impact factor: 2.894

8.  Natural history of urinary incontinence from first childbirth to 30-months postpartum.

Authors:  Krishna Patel; Jaime B Long; Sarah S Boyd; Kristen H Kjerulff
Journal:  Arch Gynecol Obstet       Date:  2021-06-27       Impact factor: 2.344

9.  Relationship between symptoms and disordered continence mechanisms in women with idiopathic faecal incontinence.

Authors:  A E Bharucha; J G Fletcher; C M Harper; D Hough; J R Daube; C Stevens; B Seide; S J Riederer; A R Zinsmeister
Journal:  Gut       Date:  2005-04       Impact factor: 23.059

10.  Impact of pelvic floor muscle training in the postpartum period.

Authors:  Louise-Helene Gagnon; Jodi Boucher; Magali Robert
Journal:  Int Urogynecol J       Date:  2015-08-19       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.